<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/defender-digicert-cert-false-positive/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-03T22:17:56.000Z</news:publication_date>
      <news:title>Defender Pulls DigiCert Root Certs in False-Positive Hit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/instructure-canvas-criminal-breach-second/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-03T15:19:01.000Z</news:publication_date>
      <news:title>Instructure Hit by Second Breach in Eight Months</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/arvinas-veppanu-first-protac-approved/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-03T14:23:14.000Z</news:publication_date>
      <news:title>FDA Clears Arvinas&apos; Veppanu, First PROTAC Drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/novartis-23b-nc-api-plant/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-02T23:19:24.000Z</news:publication_date>
      <news:title>Novartis Seals $23B US Build With NC API Plant</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/axsome-auvelity-alzheimers-agitation/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-02T22:17:03.000Z</news:publication_date>
      <news:title>FDA Approves Axsome&apos;s Auvelity for Alzheimer&apos;s Agitation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/moderna-phase-4-covid-vaccine-access/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-02T15:20:00.000Z</news:publication_date>
      <news:title>Moderna Pushes FDA on Covid Vaccine Access with Post-Marketing Data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/cisa-nsa-ai-agents-privilege-warning/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-02T14:23:35.000Z</news:publication_date>
      <news:title>Restrict AI Agent Access: Six Agencies Warn</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/minnesota-nudification-ban-500k/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-01T23:21:53.000Z</news:publication_date>
      <news:title>Passed: Minnesota&apos;s Ban on AI Nude Apps</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/cfpb-cuts-lender-data-rule-280/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-01T22:21:11.000Z</news:publication_date>
      <news:title>CFPB Cuts Lender Data Rule: 2,500 to 280</news:title>
    </news:news>
  </url>
</urlset>